ness
bronchiti
croup
bronchiol
pneumonia
primari
atyp
pneumonia
caus
virus
mycoplasma
rickettsia
chlamydia
tabl
speci
microorgan
ubiquit
occur
endem
epidem
refin
tissu
cultur
technic
earli
applic
technic
isol
identif
virus
number
virus
implic
etiolog
acut
respiratori
tract
infect
exce
tabl
adult
influenza
virus
caus
major
number
seriou
nonbacteri
respiratori
infect
upper
lower
tract
death
influenza
viru
infect
unit
state
number
sever
thousand
year
myxovirus
especi
respiratori
syncyti
viru
parainfluenza
virus
caus
seriou
respiratori
tract
diseas
infant
children
especi
infant
year
age
death
infect
adult
myxovirus
account
fewer
infect
less
sever
number
viru
group
caus
acut
respiratori
tract
infect
adult
children
includ
adenovirus
coronavirus
picornavirus
enterovirus
rhinovi
pneumonia
clinic
present
unlik
viral
mycoplasma
pneumonia
gener
group
common
nonbacteri
respiratori
infect
discuss
ruse
less
frequent
usual
less
sever
myxovirus
one
mycoplasma
speci
man
mycoplasmapnettmonia
previous
design
agent
cold
agglutininposit
primari
atyp
pneumonia
eaton
agent
caus
upper
lower
respiratori
tract
infect
mainli
implic
cold
agglutininposit
primari
atyp
pneumonia
also
caus
bullou
myring
undifferenti
febril
upper
respiratori
tract
diseas
although
occur
age
group
mycoplasma
pneumonia
infect
predomin
young
adult
importantli
infect
treat
broadspectrum
antibiot
mainli
tetracyclin
erythromycin
reason
differenti
viral
infect
rickettsia
chlamydia
organ
also
caus
pneumonia
infect
common
viru
mycoplasma
infect
morelik
suspect
specif
epidemiolog
instanc
coxiella
burnetii
q
fever
chlamydia
psittaci
psittacosi
infect
also
treat
effect
broadspectrum
antibiot
earli
diagnosi
demand
prompt
appropri
antibiot
treatment
tetracyclin
usual
drug
choic
infect
caus
agent
major
obstacl
treat
nonbacteri
respiratori
infect
difficulti
etiolog
differenti
infect
clinic
find
alon
respiratori
tract
diseas
due
virus
mycoplasma
psittacosi
etiolog
recogn
complex
symptom
sign
howev
adult
pneumonia
differenti
made
basi
epidemiolog
clinic
characterist
tabl
children
fact
clinic
syndrom
produc
varieti
nonbacteri
agent
complic
diagnost
process
tabl
introduct
new
laboratori
procedur
time
avail
mainli
research
laboratori
diagnosi
nonbacteri
respiratori
infect
accomplish
rapidli
greater
degre
certainti
tabl
nonetheless
confirm
specif
etiolog
diagnos
nonbacteri
respiratori
infect
usual
occur
retrospect
consequ
assay
acut
convalesc
r
acut
convalesc
phase
sera
pair
sera
phase
sera
rise
level
antibodi
suspect
agent
likelihood
develop
antivir
drug
within
next
year
increas
import
etiolog
diagnos
nonbacteri
respiratori
infect
sinc
drug
may
viru
specif
select
appropri
drug
base
identif
infect
viru
initi
therapi
way
antibiot
chosen
specif
therapi
seriou
bacteri
infect
certain
virus
predominantli
infect
adult
caus
seriou
respiratori
infect
older
individu
virus
mainli
caus
seriou
lower
respiratori
tract
infect
children
consid
nonbacteri
viru
infect
age
group
divisiori
arbitrari
absolut
viru
infect
predomin
pediatr
age
group
produc
respiratori
tract
infect
adult
revers
also
hold
true
thu
clinician
must
recogn
possibl
individu
age
may
one
nonbacteri
respiratori
tract
infect
see
tabl
clinic
assess
nonbacteri
respiratori
infect
requir
util
epidemiolog
clue
laboratori
diagnost
procedur
clinic
find
infect
produc
distinct
clinic
entiti
children
adult
sometim
import
clinic
differ
two
group
clue
might
assist
etiolog
differenti
emphas
whether
specif
etiolog
agent
nonbacteri
respiratori
infect
determinedand
obvious
therapeut
measur
demand
specif
etiolog
diagnosisth
approach
therapi
clinic
syndrom
outlin
consid
differenti
diagnosi
sinc
mycoplasma
pneumonia
pneumonia
q
fever
psittacosi
treat
effect
antibiot
etiolog
recognit
diseas
becom
import
clinic
consider
diagnosi
viral
respiratori
infect
howev
prevent
unnecessari
use
antibiot
allevi
longterm
complic
result
overusag
drug
epidemiolog
characterist
nonbacteri
respiratori
provid
inform
use
differenti
diagnosi
diseas
knowledg
epidemiolog
pattern
individu
microorgan
suggest
like
infect
agent
individu
ill
definit
etiolog
diagnosi
requir
specif
laboratori
test
includ
viru
isol
throat
swab
sputum
specimen
demonstr
viral
mycoplasma
antigen
exfoli
cell
nose
oropharnyx
andor
demonstr
diagnost
rise
antibodi
level
infect
organ
studi
may
wide
avail
gener
hospit
laboratori
except
demonstr
antigen
exfoli
cell
immunofluoresc
procedur
requir
sever
week
definit
answer
becom
avail
thu
physician
face
util
knowledg
epidemiolog
clinic
characterist
order
arriv
reason
etiolog
diagnosi
viral
mycoplasma
pneumonia
infect
spread
person
person
infecti
droplet
rapid
spread
commun
vari
agent
influenza
virus
spread
rapidli
involv
suscept
person
within
day
introduct
commun
virus
commun
less
quickli
mycoplasma
pneumonia
spread
slowli
famili
mycoplasma
pneumonia
eventu
infect
suscept
member
period
week
tomonth
follow
appear
first
infect
adult
influenza
viru
lesser
extent
mycoplasma
pneumonia
influenza
b
viru
caus
predomin
number
nonbacteri
respiratori
tract
infect
see
tabl
virus
psittacosi
q
fever
much
less
common
epidem
period
influenza
b
viru
infect
affect
major
suscept
adult
expos
popul
mani
individu
suffer
seriou
lower
respiratori
tract
infect
death
influenza
pneumonia
reach
major
proport
time
epidem
influenza
viru
past
decad
unit
state
death
pneumonia
influenza
quadrupl
nonbacteri
respiratori
infect
adult
occur
sporad
see
tabl
although
mycoplasma
pneumonia
pneumonia
adult
seriou
ill
fatal
record
diseas
rate
mycoplasma
ptzeumonia
pneumonia
adult
popul
much
lower
influenza
viru
infect
account
approxim
onefifth
nonbacteri
pneumonia
requir
hospit
mani
nonbacteri
pneumonia
young
adult
depend
popul
studi
viru
infect
produc
pneumonia
adult
rate
consider
less
influenza
mycoplasma
pneumonia
infect
infant
children
seriou
lower
respiratori
tract
infect
caus
number
virus
mycoplasma
pnettmonia
q
fever
psittacosi
see
tabl
howev
q
fever
psittacosi
infect
infrequ
among
virus
major
import
produc
acut
lower
respiratori
tract
diseas
parainfluenza
virus
especi
parainfluenza
type
respiratori
syncyti
viru
adenovirus
influenza
viru
coronavirus
parainfluenza
virus
occur
endem
associ
seriou
infect
throughout
year
see
tabl
outbreak
respiratori
syncyti
viru
occur
annual
sometim
decemb
april
produc
widespread
infect
suscept
infant
children
year
age
influenza
viru
infect
occur
epidem
everi
year
although
produc
seriou
lower
respiratori
tract
infect
children
pneumonia
rate
children
infect
lower
adult
influenza
virus
also
caus
bronchiol
laryngotracheobronch
acut
bronchiti
adenoviru
infect
occur
sporad
coronaviru
infect
occur
limit
outbreak
annual
less
often
mycoplasma
pneumonia
infect
uncommon
infant
children
much
less
frequent
infect
parainftuenza
respiratori
syncyti
influenza
virus
major
nonbacteri
respiratori
infect
lower
respiratori
tract
includ
pneumonia
adult
pneumonia
bronchiol
croup
infant
children
upper
respiratori
tract
infect
includ
acut
undifferenti
minor
respiratori
ill
common
cold
influenza
ill
undifferenti
febril
upper
respiratori
tract
ill
pertussislik
viral
coryza
children
croup
younger
children
subdifferenti
infraglott
type
occur
children
less
year
age
supraglott
type
found
often
older
children
etiolog
agent
involv
two
ill
differ
infraglott
croup
young
children
commonli
caus
virus
supraglott
croup
especi
occur
epiglott
commonli
caus
hemophiht
htflltellza
gener
criteria
clinic
classif
nonbacterialrespiratori
syndrom
includ
pneumonia
symptom
coryza
respiratori
distress
find
moist
rale
decreas
breath
sound
demonstr
infiltr
radiograph
examin
bronchiol
differenti
basi
mild
upper
respiratori
infect
progress
dyspnea
tachypnea
suprastern
subcost
retract
expiratori
scatter
rale
radiograph
find
air
trap
croup
laryngotracheobronch
includ
harsh
croupi
barklik
cough
stridor
sign
suggest
inspiratori
obstruct
bronchiti
character
brassi
harsh
cough
congest
rhonchi
auscult
chest
roentgenogram
usual
neg
upper
respiratori
tract
syndrom
lack
sever
fever
product
cough
respiratori
distress
presenc
constitut
manifest
malais
fatigu
anorexia
pneumonia
evid
viral
etiolog
detect
half
children
diagnosi
pneumonia
see
tabl
predomin
agent
includ
descend
order
parainfluenza
virus
type
respiratori
syncyti
viru
influenza
virus
adenovirus
mycoplasma
pneumonia
coronavirus
mix
viral
bacteri
infect
occur
infrequ
infect
suspect
antibiot
therapi
indic
clinic
differenti
viral
pneumonia
bacteri
pneumonia
difficult
extrem
tenuou
mani
case
insidi
onset
upper
respiratori
symptom
preced
increas
temperatur
dyspnea
usual
suggest
viral
etiolog
abrupt
onset
symptom
high
fever
characterist
bacteri
pneumonia
diffus
infiltr
without
pleural
fluid
seen
commonli
roentgenogram
patient
viral
pneumonia
fig
mycoplasma
pneumonia
may
also
caus
pleural
effus
low
incid
bacteremia
children
consist
fact
pneumonia
children
viral
natur
child
acut
lower
respiratori
tract
infect
present
difficult
diagnost
therapeut
problem
see
tabl
except
lung
punctur
effect
quick
method
exist
ascertain
specif
etiolog
lung
diseas
lung
punctur
highli
select
procedur
pediatrician
reli
oropharyng
swab
specimen
blood
cultur
clue
etiolog
ill
oropharyng
swab
bacteria
correl
poorli
etiolog
organ
lower
respiratori
infect
bacteremia
children
uncommon
therapi
viral
pneumonia
children
support
aim
allevi
symptom
distress
diseas
antibiot
recommend
uncompl
viral
pneumonia
children
howev
secondari
infect
develop
suspect
usual
ofhyperpyrexia
ieukocytosi
antibiot
may
use
penicillin
ampicillin
erythromycin
cephalosporin
commonli
select
mycoplasma
pneumonia
pneumonia
treatment
tetracyclin
erythromycin
bronchiol
uniqu
pediatr
diseas
usual
observ
winter
month
infant
month
age
basic
patholog
inflammatori
obstruct
bronchiol
air
trap
diseas
character
histori
upper
respiratori
tract
symptom
includ
cough
rhiniti
lowgrad
fever
last
day
progress
dyspnea
often
impress
initi
sign
physic
examin
usual
reveal
hyperem
mucou
membran
signific
find
chest
includ
rapid
shallow
respir
increas
reson
inspiratori
expiratori
wheez
may
heard
along
occasion
scatter
fine
rale
hyperaer
lung
secondari
air
trap
may
push
diaphragm
allow
palpat
liver
winter
month
diseas
almost
invari
due
respiratori
syncyti
viru
infect
epidem
respiratori
syncyti
viru
caus
increas
respiratori
tract
infect
mild
upper
respiratori
tract
ill
pneumonia
laryngotracheobronch
total
white
blood
cell
differenti
count
usual
normal
significantli
differ
normal
temperatur
usual
greater
f
chest
roentgenogram
bronchiol
show
evid
air
trap
radioluc
widen
space
rib
flat
diaphragm
fig
scatter
infiltr
area
atelectasi
occur
infrequ
therapi
bronchiol
direct
toward
reliev
obstruct
bronchial
spasm
ultrason
mist
may
use
purpos
correct
hypoxia
oxygen
vigil
bacteri
cardiac
complic
antibiot
treatment
secondari
infect
appar
suspect
constitut
main
thrust
therapi
bronchiol
intraven
fluid
given
maintain
hydrat
prevent
aspir
infant
distress
would
risk
oral
feed
bronchodil
usual
ineffect
administr
steroid
case
bronchiol
prove
benefici
except
recurr
attack
allerg
diathesi
may
involv
underli
etiolog
tracheostomi
done
last
resort
rare
necessari
differenti
diagnosi
bronchiol
consider
must
given
foreign
bodi
milk
allergi
syndrom
heiner
myocard
congest
heart
failur
asthma
certain
intoxic
eg
organophosph
laryngotracheobronchi
syndrom
laryng
tracheiti
croup
epiglott
viral
croup
reflect
vari
degre
airway
obstruct
usual
caus
inflammatori
edema
spasm
exud
local
anatom
either
glotti
diseas
seen
commonli
winter
month
predomin
male
physic
examin
respiratori
stridor
retract
hoars
bark
cough
predomin
two
distinct
form
diseas
recogn
acut
supraglott
laryng
acut
infraglott
subglott
laryng
supraglott
laryng
much
common
older
child
year
age
usual
accompani
infect
swell
epiglotti
rapidli
obstruct
caus
sever
inspiratori
distress
suffoc
death
supraglott
type
usual
caus
hemophiht
blfluenza
b
ampicillin
usual
drug
choic
note
croup
younger
age
group
month
year
caus
often
viral
infect
viral
croup
rare
obstruct
usual
run
milder
cours
supraglott
croup
epiglott
may
howev
recurr
major
agent
associ
croup
infant
parainfluenza
viru
chest
roentgenogram
pathognomon
viral
croup
usual
normal
help
elimin
possibl
aspir
foreign
bodi
therapi
viral
croup
consist
basic
support
measur
exclus
allerg
bronchiti
ingest
aspir
foreign
bodi
possibl
caus
clinic
syndrom
vigil
obstruct
mainten
hydrat
essenti
cultur
must
taken
rule
bacteri
etiolog
specif
h
hfluenza
b
c
diphtheria
diphtheria
suspect
antitoxin
penicillin
administ
immedi
isol
h
hfluenza
ampicillin
indic
croupett
therapi
cool
humid
oxygen
mist
invalu
reliev
dyspnea
stridor
hypoxia
atropin
given
mild
sedat
may
benefici
chloral
hydrat
mgkg
everi
hour
care
exercis
administr
ampicillin
mgkg
intraven
per
day
indic
epiglott
secondari
infect
suspect
intermitt
positivepressur
breath
ippb
treatment
aerosol
racem
epinephrin
vaponefrin
dilut
normal
salin
repeat
everi
minut
may
great
benefit
tracheostomi
may
lifesav
croup
epiglott
control
studi
steroid
shown
effect
reliev
distress
viral
croup
although
use
wide
upper
respiratori
tract
infect
coryza
bronchiti
pharyng
without
rhiniti
respons
ill
children
caus
virus
invad
passag
upper
respiratori
tract
extend
lower
air
passag
result
bronchiti
frequent
associ
laryng
lowgrad
fever
coars
breath
sound
rhonchi
chest
roentgenogram
usual
normal
show
perihilar
infiltr
total
leukocyt
count
normal
therapi
consist
expector
antituss
decongest
antihistamin
secondari
infect
suspect
antibiot
also
may
import
treatment
bronchiti
child
recurr
lower
respiratori
tract
infect
present
special
diagnost
challeng
physician
either
child
experienc
multipl
infect
differ
microorgan
unrecogn
chronic
ill
repeat
exacerb
essenti
caus
recurr
nonbacteri
respiratori
infect
includ
allerg
environment
famili
factor
immun
defici
congenit
abnorm
tracheobronchi
esophag
pathway
innat
lung
diseas
asthma
cystic
fibrosi
pulmonari
hemosiderosi
bronchopulmonari
dysplasia
search
underli
diseas
must
includ
investig
specif
nonbacteri
respiratori
tract
infect
mean
laboratori
test
aim
isol
organ
determin
antibodi
respons
also
must
encompass
test
necessari
search
one
underli
caus
respect
follow
discuss
highlight
recommend
procedur
investig
natur
predispos
underli
chronic
ill
detail
histori
uncov
inform
possibl
allerg
famili
environment
factor
may
play
role
recurr
chronic
day
care
nurseri
school
children
particularli
prone
recurr
viral
ill
frequent
exposur
repeat
contact
infect
playmat
underli
allerg
diathesi
probabl
repres
common
caus
recurr
lower
respiratori
tract
ill
children
allerg
rhiniti
persist
intermitt
wheez
come
famili
histori
allergi
seem
suscept
recurr
viral
infect
involv
signific
percentag
offic
visit
nasal
smear
eosinophil
scratch
test
use
especi
inhal
antigen
may
help
determ
antigen
sensit
possibl
immun
disord
hypogammaglobulinemia
may
suggest
chronic
gastroenter
persist
oral
moniliasi
signific
leukopenia
usual
involv
small
lymphocyt
thrombocytopenia
chest
roentgenogram
rereview
evalut
thymic
shadow
lymphoid
tissu
absenc
thymic
shadow
suggest
immun
diseas
quantit
assay
immunoglobulin
may
indic
select
immun
defici
delay
matur
antibodi
transient
hypogammaglobulinemia
associ
recurr
infect
children
year
age
skin
test
includ
mantoux
schick
c
albican
appli
presumpt
test
patient
compet
delay
hypersensit
definit
test
delay
hypersensit
cellular
immun
dinitrofluorobenzen
dnfb
skin
test
invitro
lymphocyt
stimul
abnorm
cardiac
silhouett
electrocardiogram
suggest
congenit
heart
diseas
barium
swallow
perform
explor
presenc
vascular
tracheoesophag
anomali
h
type
fistula
suspect
diagnosi
must
made
bronchoesophagoscopi
cineradiographi
select
case
lung
punctur
biopsi
may
consid
h
type
fistula
rare
type
congenit
abnorm
esophagu
defect
atresia
esophagu
complet
connect
esophagu
trachea
resembl
letter
h
nonbacteri
upper
respiratori
tract
ill
adult
includ
sever
syndrom
design
common
cold
minor
undifferenti
upper
respiratori
infect
febril
upper
respiratori
diseas
especi
influenza
influenzalik
diseas
discuss
nonbacteri
upper
respiratori
tract
ill
consid
broadli
either
afebril
febril
major
number
febril
upper
respiratori
tract
ill
usual
caus
influenza
viru
myxovirus
coronavirus
adenovirus
account
small
proport
ill
afebril
upper
respiratori
tract
ill
caus
virus
capabl
infect
respiratori
tract
especi
rhinovirus
myxovirus
enterovirus
coronavirus
adenovirus
mycoplasma
pneumonia
associ
syndrom
importantli
etiolog
differenti
upper
respiratori
tract
ill
accomplish
basi
clinic
find
alon
afebril
upper
respiratori
tract
ill
character
nasal
discharg
nasal
obstruct
patient
nonproduct
cough
approxim
twothird
patient
less
often
chilli
sensat
myalgia
may
occur
febril
upper
respiratori
tract
ill
fever
chill
predomin
myalgia
fatigu
muscl
ach
occur
frequent
nasal
symptom
occur
patient
patient
experi
sore
throat
hoars
well
ill
selflimit
short
durat
treatment
nonbacteri
upper
respiratori
tract
ill
consist
support
measur
aim
minim
symptom
infect
histor
term
primari
atyp
pneumonia
first
use
earli
connot
acut
lower
respiratori
tract
infect
nonbacteri
etiolog
ill
atyp
typic
bacteri
pneumococc
pneumonia
time
implicit
use
term
primari
atyp
pneumonia
consider
one
specif
yet
undiscov
microorgan
caus
ill
primari
atyp
pneumonia
compris
group
pneumonia
ill
whose
etiolog
includ
number
differ
microorgan
particularli
mycoplasma
pneumonia
virus
bacteria
mycoplasma
pneumonia
earlier
design
agent
primari
atyp
pneumonia
eaton
agent
recogn
etiolog
agent
cold
agglutininposit
primari
atyp
pneumonia
late
mycoplasma
smallest
microorgan
capabl
growth
cellfre
medium
millimicron
size
pleomorph
shape
contain
dna
rna
lack
rigid
cell
wall
possess
triplelay
outer
membran
replic
intracellularli
extracellularli
mycoplasma
pneumonia
produc
hemolysin
peroxid
unlik
virus
sensit
treatment
tetracyelin
erythromycin
knowthat
equivoc
suggest
result
doubleblind
antibiot
treatment
studi
primari
atyp
pneumonia
conduct
depend
proport
mycoplasma
pneumonia
infect
studi
group
distribut
treatment
placebo
group
recognit
mycoplasma
pneumonia
caus
cold
agglutininposit
primari
atyp
pneumonia
character
diseas
permit
specif
delin
appropri
refer
mycoplasma
pneltmonia
pneumonia
addit
number
virus
shown
caus
pneumonia
especi
myxovirus
adenovirus
also
design
specif
etiolog
name
less
less
use
made
term
primari
atyp
pneumonia
etiolog
agent
identifi
among
caus
nonbacteri
pneumonia
adult
influenza
viru
mycoplasma
pneuntonia
infect
predomin
see
tabl
virus
produc
pneumonia
adult
includ
adenovirus
parainfluenza
virus
respiratori
syncyti
viru
infrequ
varicella
psittacosi
q
fever
uncommon
caus
pneumonia
adult
clinic
featur
allow
differenti
etiolog
nonbacteri
pneumonia
adult
without
recours
laboratori
diagnost
procedur
howev
occurr
certain
clinic
epidemiolog
find
may
suggest
physician
specif
caus
diseas
see
tabl
confirm
ident
infect
organ
must
obtain
laboratori
diagnosi
mycoplasma
pneumonia
pneumonia
mycoplasma
pneumonia
pneumonia
cough
frequent
initi
find
usual
nonproduct
first
day
ill
becom
product
hemoptysi
rare
occur
earli
predomin
find
hemoptysi
suggest
etiolog
agent
mycoplasma
pneumonia
headach
chill
malais
rhinorrhea
chest
pain
gener
muscl
ach
occur
half
patient
nearli
patient
develop
fever
rale
may
develop
first
day
ill
occur
least
fourfifth
patient
patient
mycoplasma
pneumonia
pneumonia
uniqu
may
develop
bullou
myring
tympan
untreat
case
fever
usual
last
week
rale
cough
malais
fatigu
radiograph
abnorm
persist
week
small
number
patient
experi
fever
last
week
abnorm
radiograph
find
last
long
month
rare
instanc
residu
pleural
abnorm
found
chest
roentgenogram
leukocytosi
develop
onesixth
case
sediment
rate
elev
onefourth
case
bacteri
superinfect
rare
occur
mycoplasma
pneumonia
pneumonia
mycoplasma
pneumonia
pneumonia
specif
radiograph
pattern
prevail
often
pneumon
infiltr
unilater
locat
lower
lobe
fig
onefifth
patient
bilater
involv
fig
infiltr
process
mycoplasma
pnetlmonia
pneumonia
appear
patchi
fluffi
characterist
infiltr
show
punctat
mottl
infiltr
bronchiolar
peribronchiolar
gener
follow
cours
bronchovascular
mark
lobar
involv
distinctli
unusu
patient
develop
infiltr
middl
upper
lobe
radiograph
pictur
must
differenti
acut
pulmonari
tuberculosi
pleural
effus
occur
mycoplasma
pneumonia
pneumonia
perhap
l
fig
mycoplasma
pneumonia
pneumonia
infiltr
extend
right
hilum
right
lower
lobe
patient
less
often
adult
children
may
difficult
obtain
fluid
thoracentesi
small
collect
pleural
fluid
fluid
serou
high
protein
content
approxim
gm
ml
small
number
patient
mycoplasma
pneumonia
pneumonia
usual
adolesc
may
develop
central
nervou
system
complic
involv
cerebrum
cerebellum
spinal
cord
nerv
root
mening
encephali
ti
cerebellar
ataxia
psychosi
report
also
residu
neurolog
abnorm
occur
small
signific
number
patient
sinc
appear
central
nervou
system
abnorm
viral
pneumonia
rare
find
encourag
search
mycoplasma
pneumonia
infeciion
develop
cold
agglutinin
titer
exceed
cours
nonbacteri
pneumonia
pre
cold
agglutinin
appear
frequent
sever
ill
patient
overal
half
individu
mycophzsma
pneumonia
pneumonia
develop
cold
agglutinin
specif
mycoplasma
plleltmonia
antibodi
measur
complement
fixat
metabol
inhibit
immunofluoresc
develop
convalesc
nearli
patient
infect
see
tabl
treatment
mycoplasma
pneumonia
pneumonia
includ
addit
specif
antimicrobi
therapi
bed
rest
adequ
diet
liquid
salicyl
antituss
medic
bronchodil
drug
requir
respiratori
distress
tetracyclin
gm
daili
divid
dose
erythromycin
gm
daili
divid
dose
day
effect
treat
diseas
lessen
sever
symptom
sign
shorten
cours
ill
antibiot
given
diseas
abat
also
effect
treatment
diseas
one
tetracyclin
analogu
oxytetracyclin
chlortetracyclin
demethylchlortetracyclin
appropri
dose
recurr
pneumonia
mycoplasma
pneumonia
infect
occur
infrequ
respond
retreat
although
antimicrobi
therapi
lessen
sever
diseas
shorten
ill
immedi
erad
organ
respiratori
tract
patient
therapi
still
may
shed
organ
respiratori
secret
influenza
viru
pneumonia
ihfluenza
viru
pneumonia
common
caus
pneumonia
adult
frequent
caus
hospit
nonbacteri
pneumonia
present
primari
influenz
pneumonia
onefourth
case
influenza
infect
primari
influenz
pneumonia
occur
predominantli
pregnant
women
patient
rheumat
heart
diseas
patient
influenza
frequent
develop
complic
bacteri
superinfect
pneumonia
influenza
b
viru
infrequ
caus
pneumonia
primari
influenz
pneumonia
character
involv
lower
respiratori
tract
typic
influenz
ill
high
fever
develop
readili
abat
cough
tachypnea
dyspnea
promin
cough
paroxysm
may
nonproduct
begin
ill
headach
sore
throat
promin
muscl
ach
fatigu
anorexia
sign
bronchiti
occasion
hemoptysi
character
influenz
viru
pneumonia
rale
appear
patient
absenc
bacteri
superinfect
physic
sign
consolid
unusu
radiograph
examin
infiltr
appear
diffus
usual
bilater
patient
complic
diseas
rheumat
heart
diseas
chronic
lung
diseas
pneumonia
rapidli
progress
case
fatal
rate
high
sign
focal
consolid
develop
presenc
bacteri
superinfect
usual
pneumococci
staphylococci
hemophilu
hlfluenza
leukocytosi
occur
primari
influenz
pneumonia
usual
rang
cellsram
whether
ill
complic
bacteri
infect
patient
primari
influenz
pneumonia
treat
gener
support
measur
includ
bed
rest
adequ
diet
liquid
salicyl
oxygen
nasal
mask
ippb
devic
respiratori
distress
dyspnea
predomin
unless
bacteri
superinfect
interven
influenza
viru
pneumonia
antibiot
therapi
requir
superinfect
bacteria
demand
rapid
initi
antibiot
therapi
direct
infect
organ
amantadin
effect
prophylaxi
influenza
viru
infect
see
section
viru
vaccin
viral
chemotherapi
sign
symptom
infect
develop
drug
ineffect
pneumonia
adenoviru
pneumonia
occur
infrequ
adult
found
often
among
special
popul
group
especi
militari
recruit
militari
recruit
adenovirus
often
produc
pneumonia
well
sever
febril
upper
respiratori
tract
diseas
fatal
among
adult
extrem
rare
report
select
sharp
outbreak
diseas
among
children
common
infect
type
young
adult
type
contrast
usual
childhood
infect
type
adenoviru
pneumonia
character
cough
chill
sore
throat
rhinorrhea
less
often
headach
gener
muscl
ach
fever
predomin
twothird
patient
develop
rale
tonsillar
exud
develop
onefourth
patient
suggest
adenoviru
infect
pharyng
erythema
occur
onefifth
patient
radiograph
infiltr
usual
unilater
confin
lower
lobe
frequent
bilater
andor
involv
hilar
region
characterist
featur
infiltr
resembl
mycoplasma
pneumonia
pneumonia
bronchiolar
peribronchiolar
pattern
predomin
infiltr
fluffi
patchi
bacteri
superinfect
adenoviru
pneumonia
occur
rare
treatment
adenoviru
pneumonia
includ
gener
support
measur
aim
reliev
distress
fever
ill
allevi
respiratori
distress
nonbacteri
pneumonia
viral
pneumonia
associ
parainfluenza
viru
respiratori
syncytiai
viru
enteroviru
measl
varicella
infect
case
uncommon
presenc
pathognomon
find
measleg
chickenpox
permit
etiolog
recognit
psittacosi
q
fever
also
infrequ
caus
nonbacteri
pneumonia
treat
effect
antibiot
varicella
pneumonia
develop
within
first
week
rash
chickenpox
appear
character
cough
pleurit
chest
pain
hemoptysi
fever
respiratori
distress
hemoptysi
last
sever
day
contrast
pleurit
chest
pain
hemoptysi
infrequ
rare
viral
pneumonia
mycoplasma
pneumonia
pneumonia
physic
find
frequent
beli
sever
ill
varicella
pneumonia
adventiti
sound
rhonchi
wheez
found
chest
roentgenogram
howev
show
bilater
infiltr
first
nodular
develop
definit
acinar
pattern
hilar
adenopathi
usual
onethird
patient
leukocytosi
convalesc
complementfix
antibodi
varicella
viru
develop
serolog
diagnosi
infect
made
detect
fourfold
greater
rise
antibodi
pair
sera
death
varicella
pneumonia
approach
case
usual
caus
respiratori
insuffici
treatment
varicella
pneumonia
includ
support
measur
immun
incompet
patient
zoster
immun
globulin
zig
may
given
singl
intramuscular
inject
see
section
viru
vaccin
viral
chemotherapi
adren
corticosteroid
although
ordinarili
indir
treatment
varicella
pneumonia
may
use
sever
case
complic
shock
psittacosi
complic
pneumonia
acquir
man
contact
infect
bird
occup
hazard
bird
handler
pet
shop
industri
appear
symptom
sign
ensu
within
week
exposur
includ
high
fever
headach
chilli
sensat
sore
throat
product
cough
photophobia
nausea
vomit
sputum
may
ting
blood
pneumonia
diffus
interstiti
fine
rale
may
detect
auscult
hepatosplenomegali
occur
infrequ
psittacosi
pneumonia
persist
week
treatment
choic
tetracyclin
gm
daili
divid
dose
administ
week
abat
ill
convalesc
specif
complementfix
antibodi
develop
chlamydia
psittaci
fourfold
greater
rise
antibodi
diagnost
infect
see
tabl
presumpt
specif
diagnosi
made
singl
serum
avail
detect
titer
greater
although
organ
isol
sputum
blood
acut
phase
ill
agent
easili
transmit
laboratori
worker
unless
rigid
contain
procedur
use
routin
diagnost
examin
nonbacteri
pneumonia
attempt
isol
chlamydia
psittaci
especi
inexperienc
personnel
areunwarr
q
fever
pneumonia
contract
ingest
contamin
milk
exposur
aerosol
infect
fece
sheep
goat
cattl
although
anim
becom
infect
coxiella
burnetii
tick
bite
man
sign
symptom
appear
abruptli
characterist
includ
sever
headach
fever
chill
malais
myalgia
rash
pneumonia
usual
unilater
occur
approxim
onehalf
case
hepatosplenomegali
frequent
develop
q
fever
usual
last
sever
week
nearli
patient
recov
without
incid
serolog
diagnosi
infect
made
detect
fourfold
greater
rise
complementfix
antibodi
convalesc
q
fever
fail
react
weilfelix
test
proteu
vulgari
psittacosi
isol
organ
attempt
except
unusu
circumst
sinc
highli
contagi
tetracyclin
gm
daili
divid
dose
treatment
choic
continu
day
ill
resolv
major
defens
mechan
nonbacteri
infect
iga
secretori
antibodi
system
iga
one
four
major
protein
found
nasal
secret
along
albumin
small
amount
igg
gamma
globulin
siderophilin
signific
compon
nasal
secret
primarili
function
local
immun
secretori
iga
sediment
coeffici
addit
antigen
characterist
differenti
circul
serum
iga
structur
secretori
iga
compos
h
chain
l
chain
plu
uniqu
compon
design
transport
piec
transport
piec
play
role
passag
iga
cell
surfac
secretori
iga
act
secretori
iga
found
secret
upper
lower
respiratori
tract
parotid
saliva
colostrum
tear
defens
function
secretori
iga
suggest
major
product
follow
topic
immun
intranas
pharyng
instil
antigen
contrast
littl
respons
secretori
iga
antibodi
occur
respons
immun
system
rout
lga
appear
respiratori
tract
secret
synthes
local
plasma
cell
adjac
tissu
diminish
host
resist
may
relat
select
iga
defici
affect
patient
may
recurr
lower
respiratori
tract
infect
allerg
syndrom
autoimmun
disord
may
appear
healthi
adult
combin
defici
iga
cellmedi
immun
contribut
develop
sever
respiratori
tract
infect
hypogammaglobulinemia
infanc
selflimit
disord
character
delay
matur
igg
synthesi
normal
declin
transplacent
antibodi
first
month
life
signific
delay
gamma
globulin
synthesi
usual
normal
level
immunoglobulin
attain
year
age
respiratori
tract
infect
common
period
immunoglobulin
level
low
usual
ml
gamma
globulin
may
given
affect
infant
sever
symptom
addit
recurr
respiratori
ill
includ
failur
thrive
intermitt
diarrhea
miscellan
dysgammaglobulinemia
may
also
associ
increas
suscept
infect
commonli
pattern
immunoglobulin
show
absenc
circul
iga
igm
low
level
igg
altern
anoth
type
dysgammaglobulinemia
igm
increas
total
immunoglobulin
level
exceed
ml
detect
quantit
radial
immunodiffus
determin
exclud
immunoglobulin
defici
syndrom
gener
recognit
hypogammaglobulinemia
children
signal
total
immunoglobulin
level
less
ml
igg
level
less
ml
gamma
globulin
therapi
remain
controversi
consid
iggdefici
patient
commerci
gamma
globulin
deriv
pool
sera
contain
almost
exclus
igg
initi
dose
mlkg
intramuscularli
follow
mainten
dose
mlkg
given
everi
week
month
although
certain
laboratori
test
use
diagnosi
nonbacteri
respiratori
infect
provid
specif
inform
quit
rapidli
major
limit
procedur
requir
day
week
definit
answer
either
posit
neg
avail
see
tabl
moreov
present
test
may
done
small
hospit
state
health
depart
laboratori
newer
test
avail
mainli
medic
center
research
facil
three
type
laboratori
test
develop
diagnosi
nonbacteri
respiratori
infect
immunofluoresc
identif
viral
antigen
exfoli
cell
respiratori
tract
isol
identif
infect
microorgan
respiratori
secret
demonstr
rise
antibodi
acut
convalesc
serum
specimen
first
test
immunofluoresc
identif
viral
antigen
respiratori
tract
cell
provid
rapid
mean
specif
diagnosi
depend
infect
agent
isol
procedur
requir
day
week
test
posit
neg
test
requir
least
week
final
report
return
necess
antibodi
studi
done
retrospect
sinc
requir
second
serum
specimen
obtain
convalesc
singl
serum
specimen
use
except
unusu
circumst
exampl
singl
high
titer
cold
agglutinin
obtain
earli
phase
pneumon
ill
provid
presumpt
definit
evid
convalesc
serum
specimen
must
test
parallel
rise
cold
agglutinin
antibodi
specif
mycoplasma
pneumonia
antibodi
well
confirm
diagnosi
infect
present
immunofluoresc
identif
viru
antigen
exfoli
cell
special
procedur
limit
avail
applic
influenza
parainfluenza
respiratori
syncyti
viru
infect
respiratori
tract
detect
method
cell
scrape
nasal
oropharyng
mucosa
smear
slide
gentli
fix
aceton
overlaid
fluoresceinconjug
antibodi
viru
question
separ
test
slide
serum
requir
although
test
complet
hour
requir
skill
technician
care
attent
control
avail
certifi
reagent
isol
infect
microorgan
respiratori
tract
secret
done
quit
easili
unlik
bacteri
isol
procedur
requir
sever
week
recov
identifi
either
virus
mycoplasma
pneumonia
nasal
swab
oropharyng
swab
sputum
specimen
use
viru
isol
materi
inocul
sever
tube
tissu
cultur
incub
examin
interv
fo
evid
viru
growth
characterist
chang
cell
presumpt
identif
isol
viru
made
specif
identif
requir
serolog
test
may
take
sever
week
complet
often
presumpt
identif
provid
enough
inform
aid
manag
patient
diseas
isol
mycoplasma
pneumonia
mycoplasma
sputum
inocul
onto
two
plate
pplo
agar
heavi
streak
one
plate
incub
aerob
anaerob
interv
plate
examin
lowpow
microscopi
mycoplasma
coloni
sinc
speci
mycoplasma
found
respiratori
tract
similar
coloni
morpholog
specif
identif
organ
must
made
serolog
measur
preliminari
way
mycoplasma
tent
identifi
mycoplasma
pneumonia
grow
aerob
produc
beta
hemolysi
guinea
pig
erythrocyt
overlaid
matur
coloni
suspens
red
blood
cell
light
agar
solut
gener
avail
either
test
antibodi
assay
provid
specif
rel
easi
mean
identifi
agent
nonbacteri
respiratori
infect
usual
acut
convalesc
serum
specimen
test
simultan
number
oforgan
known
produc
respiratori
tract
infect
demonstr
fourfold
greater
rise
antibodi
acut
phase
specimen
convalesc
phase
specimen
evid
recent
infect
specif
agent
serum
specimen
tempor
relat
onset
ill
convalesc
patient
multipl
antibodi
rise
occur
number
instanc
must
interpret
light
known
antigen
relationship
virus
epidemiolog
inform
viru
preval
commun
time
antibodi
test
avail
virus
mycoplasma
rickettsia
chlamydia
organ
conveni
diagnost
rise
sought
mean
complement
fixat
procedur
although
involv
neutral
hemagglutinationinhibit
immunofluoresc
procedur
avail
agent
cold
agglutinin
de
pleuropneumonialik
organ
termin
mycoplasnm
pneumonia
infect
suspect
although
half
patient
usual
sever
ill
develop
nonspecif
antibodi
convalesc
posit
test
cold
agglutinin
nonbacteri
respiratori
infect
gener
exclud
nonbacteri
agent
present
immunoprophylaxi
nonbacteri
respiratori
infect
avail
influenza
viru
infect
vaccin
compris
recent
preval
strain
two
type
singl
type
b
strain
formaldehydeinactiv
egggrown
antigen
although
experiment
inactiv
live
attenu
viru
vaccin
prepar
studi
volunt
parainfluenza
virus
respiratori
syncyti
viru
mycoplasma
pneumonia
vaccin
licens
gener
use
remain
development
stage
larg
number
rhinovirus
type
enterovirus
type
associ
respiratori
tract
infect
develop
vaccin
number
involv
major
infect
seem
practic
mean
direct
treatment
infect
must
sought
influenza
viru
vaccin
recommend
person
suffer
chronic
debilit
diseas
especi
congenit
rheumat
heart
diseas
hypertens
arteriosclerot
heart
diseas
chronic
respiratori
diseas
diabet
mellitu
chronic
metabol
disord
age
individu
individu
employ
essenti
commun
servic
less
regular
interv
influenza
virus
undergo
minor
major
chang
surfac
antigen
requir
use
recent
recogn
defin
antigen
type
vaccin
major
surfac
antigen
influenza
viru
includ
hemagglutinin
neuramidinas
activ
viru
antigen
may
chang
either
singli
togeth
preval
influenza
strain
achiev
effect
level
antibodi
vaccin
given
annual
cours
immun
inactiv
bival
influenza
viru
vaccin
consist
singl
inject
ml
administ
subcutan
person
previous
vaccin
singl
inject
ml
subcutan
given
annual
basi
live
attenu
viru
vaccin
influenza
viru
develop
consist
recombin
strain
influenza
viru
preval
strain
use
along
older
nonvirul
strain
induc
high
level
antibodi
method
recombin
strain
induc
high
level
antibodi
antigen
contain
recent
preval
strain
produc
rapidli
howev
vaccin
still
experiment
requir
addit
test
made
avail
gener
use
present
effect
drug
avail
use
treatment
viral
respiratori
infect
howev
one
drug
amantadin
adamantanamin
hydrochlorid
avail
specif
chemic
prophylaxi
influenza
type
infect
amantadin
impair
penetr
influenza
viru
host
cell
must
given
advanc
infect
achiev
maxim
effect
drug
given
oral
absorb
gastrointestin
tract
excret
urin
essenti
drug
given
highrisk
individu
outbreak
influenza
viru
strain
recogn
commun
dose
adult
mg
daili
higher
daili
dose
infrequ
produc
central
nervou
system
sideeffect
includ
nervous
dizzi
inabl
concentr
depress
highrisk
group
especi
level
immun
current
influenza
viru
strain
might
expect
low
amantadin
given
along
immun
inactiv
influenza
viru
vaccin
medic
continu
antibodi
respons
develop
amantadin
contraind
pregnant
women
varicella
pneumonia
especi
individu
defect
antibodi
product
immun
serum
globulin
modifi
sever
diseas
dose
adult
ml
intramuscularli
children
lb
zoster
immun
globulin
effici
prepar
patient
convalesc
herp
zoster
infect
contain
high
titer
specif
antibodi
dose
adult
ml
intramuscularli
children
kg
obtain
center
diseas
control
atlanta
georgia
